Bibliografía
1. Nolting D, Hansen BF, Keeling J, et al: Prenatal deve-
lopment of the normal human vertebral corpora in
different segments of the spine. Spine 23:2265–2271,
1998.
2. Weidenheim KM, Kress Y, Epshteyn I, et al: Early
myelination in the human fetal lumbosacral spinal
cord: Characterization by light and electron micros-
copy. J Neuropathol Exp Neurol 51:142–149, 1992.
3. Tanaka S, Mito T, Takashima S: Progress of myelina-
tion in the human fetal spinal nerve roots, spinal
cord and brainstemwith myelin basic protein immu-
nohistochemistry. Early Hum Dev 41:49–59, 1995.
4. Dalens B: Nociception and pain. In Dalens B (ed):
Regional Anesthesia in Infants, Children and Ado-
lescents. London, Williams & Wilkins, 1995, pp 35.
5. Wolf AR: Development and evaluation of pain and
the stress response. In Bissonnette B, Dalens B (eds):
Pediatric Anesthesia: Principles and Practice. New
York, McGraw-Hill, 2002, pp 187.
6. Anand KJ: Pain, plasticity, and premature birth: A
prescription for permanent suffering? Nat Med
6:971–973, 2000.
7. Grunau R: Early pain in preterm infants: A model
of long-term effects. Clin Perinatol 29:373–394,
2002.
8. Taddio A, Katz J: The effects of early pain experience
in neonates on pain responses in infancy and child-
hood. Paediatr Drugs 7:245–257, 2005.
9. Lack JA, Stuart-Taylor ME: Calculation of drug
dosage and body surface area of children. Br J
Anaesth 78:601–605, 1997.
10. Mazoit JX, Dalens BJ: Pharmacokinetics of local
anaesthetics in infants and children. Clin Pharma-
cokinet 43:17–32, 2004.
11. Mazoit JX, Denson DD, Samii K: Pharmacokinetics
of bupivacaine following caudal anesthesia in
infants. Anesthesiology 68:387–391, 1988.
12. Booker PD, Taylor C, Saba G: Perioperative changes
in alpha 1-acid glycoprotein concentrations in
infants undergoing major surgery. Br J Anaesth
76:365–368, 1996.
13. Meunier JF, Goujard E, Dubousset AM, et al: Phar-
macokinetics of bupivacaine after continuous epi-
dural infusion in infants with and without biliary
atresia. Anesthesiology 95:87–95, 2001.
14. Eyres RL, Bishop W, Oppenheim RC, Brown TCK:
Plasma bupivacaine concentrations in children
during caudal epidural analgesia. Anaesth Intens
Care 11:20–22, 1983.
15. Eyres RL, Hastings C, Brown TCK, Oppenheim RC:
Plasma bupivacaine concentrations following
lumbar epidural anaesthesia in children. Anaesth
Intens Care 14:131–134, 1986.
16. Lonnqvist PA, Westrin P, Larsson BA, et al: Ropiva-
caine pharmacokinetics after caudal block in 1-8 year
old children. Br J Anaesth 85:506–511, 2000.
17. Ala-Kokko TI, Partanen A, Karinen J, et al: Pharma-
cokinetics of 0.2% ropivacaine and 0.2% bupiva-
caine following caudal blocks in children. Acta
Anaesthesiol Scand 44:1099–1102, 2000.
18. Karmakar MK, Aun CST, Wong ELY, et al: Ropiva-
caine undergoes slower systemic absorption from
the caudal epidural space than bupivacaine. Anesth
Analg 94:259–265, 2002.
19. Chalkiadis GA, Eyres RL, Cranswick N, et al: Phar-
macokinetics of 0.25% levobupivacaine following
caudal administration in children under 2 years of
age. Br J Anaesth 92:218–222, 2004.
20. Chalkiadis GA, Anderson BJ, Tay M, et al: Pharma-
cokinetics of levobupivacaine after caudal epidural
administration in infants less than 3 months of age.
Br J Anaesth 95:524–529, 2005.
21. Peutrell JM, Holder K, Gregory M: Plasma bupiva-
caine concentrations associated with continuous
extradural infusions in babies. Br J Anaesth 78:160–
162, 1997.
22. Luz G, Innerhofer P, Bachmann B, et al: Bupivacaine
plasma concentrations during continuous epidural
anesthesia in infants and children. Anesth Analg
82:231–234, 1996.
23. Luz G, Wieser C, Innerhofer P, et al: Free and total
bupivacaine plasma concentrations after continuous
epidural anaesthesia in infants and children. Pae-
diatr Anaesth 8:473–478, 1998.
24. Lerman J, Nolan J, Eyres R, et al: Efficacy, safety, and
pharmacokinetics of levobupivacaine with and
without fentanyl after continuous epidural infusion
in children: A multicenter trial. Anesthesiology
99:1166–1174, 2003.
25. Bosenberg AT, Thomas J, Cronje L, et al: Pharmaco-
kinetics and efficacy of ropivacaine for continuous
epidural infusion in neonates and infants. Paediatr
Anaesth 15:739–749, 2005.
26. Leopold A, Wilson S, Weaver JS, et al: Pharmacoki-
netics of lidocaine delivered from a transmucosal
patch in children. Anesth Prog 49:82–87, 2002.
27. Gjonaj ST, Lowenthal DB, Dozor AJ: Nebulized lido-
caine administered to infants and children under-
going flexible bronchoscopy. Chest 112:1665, 1997.
28. Sitbon P, Laffon M, Lesage V, et al: Lidocaine plasma
concentrations in pediatric patients after providing
airway topical anesthesia from a calibrated device.
Anesth Analg 82:1003, 1996.
29. Nielson DW, Ku PL, Egger M: Topical lidocaine exa-
ggerates laryngomalacia during flexible bronchos-
copy. Am J Respir Crit Care Med 161:147–151,
2000.
30. Engberg G, Danielson K, Henneberg S, Nilsson K:
Plasma concentrations of prilocaine and lidocaine
and methaemoglobin formation in infants after epi-
cutaneous application of a 5% lidocaine-prilocaine
cream (EMLA). Acta Anaesthesiol Scand 31:624–
628, 1987.
31. Doyle E, Morton NS, McNicol LR: Plasma bupiva-
caine levels after fascia iliaca compartment block
with and without adrenaline. Paediatr Anaesth
7:121–124, 1997.
32. Weston PJ, Bourchier D: The pharmacokinetics of
bupivacaine following interpleural nerve block in
infants of very low birthweight. Paediatr Anaesth
5:219–222, 1995.
33. Smith T, Moratin P, Wulf H: Smaller children have
greater bupivacaine plasma concentrations after
ilioinguinal block. Br J Anaesth 76:452–455, 1996.
34. Dalens B, Ecoffey C, Joly A, et al: Pharmacokinetics
and analgesic effect of ropivacaine following ilioin-
guinal/iliohypogastric nerve block in children. Pae-
diatr Anaesth 11:415–420, 2001.
35. Paut O, Schreiber E, Lacroix F, et al: High plasma
ropivacaine concentrations after fascia iliaca com-
partment block in children. Br J Anaesth 92:416–
418, 2004.
36. Bokesch PM, Castaneda AR, Ziemer G, Wilson JM:
The influence of a right-to-left cardiac shunt on
lidocaine
pharmacokinetics.
Anesthesiology
67:739–744, 1987.
37. Thomas J, Long G, Moore G, Morgan D: Plasma
protein binding and placental transfer of bupiva-
caine. Clin Pharmacol Ther 19:426–434, 1976.
38. Papini O, Mathes AC, Cunha SP, Lanchote VL: Ste-
reoselectivity in the placental transfer and kinetic
disposition of racemic bupivacaine administered to
parturients with or without a vasoconstrictor. Chi-
rality 16:65–71, 2004.
39. Zsigmond EK, Downs JR: Plasma cholinesterase
activity in newborns and infants. Can Anaesth Soc
J 18:278–285, 1971.
40. Bricker SR, Telford RJ, Booker PD: Pharmacokine-
tics of bupivacaine following intraoperative intercos-
tal nerve block in neonates and in infants aged less
than 6 months. Anesthesiology 70:942–947, 1989.
41. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford
NH: Developmental pharmacokinetics of morphine
and its metabolites in neonates, infants and young
children. Br J Anaesth 92:208–217, 2004.
42. Attia J, Ecoffey C, Sandouk P, et al: Epidural mor-
phine in children: Pharmacokinetics and CO
2
sen-
sitivity. Anesthesiology 65:590–594, 1986.
43. Wolf AR, Hughes D, Hobbs AJ, et al: Combined
morphine-bupivacaine caudals for reconstructive
penile surgery in children: Systemic absorption of
morphine and postoperative analgesia. Anaesth
Intensive Care 19:17–21, 1991.
44. Warner MA, Kunkel SE, Offord KO, et al: The effects
of age, epinephrine, and operative site on duration
of caudal analgesia in pediatric patients. Anesth
Analg 66:995–998, 1987.
45. Hansen TG, Morton NS, Cullen PM, et al: Plasma
concentrations and pharmacokinetics of bupiva-
caine with and without adrenaline following caudal
anaesthesia in infants. Acta Anaesthesiol Scand
45:42–47, 2001.
46. Bouaziz H, Okubo N, Malinovsky JM, et al: The age-
related effects of epidural lidocaine, with and without
epinephrine, on spinal cord blood flow in anestheti-
zed rabbits. Anesth Analg 88:1302–1307, 1999.
47. Jamali S, Monin S, Begon C, et al: Clonidine in
pediatric caudal anesthesia. Anesth Analg 78:663–
666, 1994.
48. De Negri P, Ivani G, Visconti C, et al: The dose-
response relationship for clonidine added to a
postoperative continuous epidural infusion of ropi-
vacaine in children. Anesth Analg 93:71–76, 2001.
49. Kaabachi O, Zarghouni A, Ouezini R, et al: Cloni-
dine 1microg/kg is a safe and effective adjuvant to
plain bupivacaine in spinal anesthesia in adoles-
cents. Anesth Analg 105:516–519, 2007.
50. Cucchiaro G, Ganesh A: The effects of clonidine on
postoperative analgesia after peripheral nerve bloc-
kade in children. Anesth Analg 104:532–537, 2007.
51. Bouchut JC, Dubois R, Godard J: Clonidine in pre-
term-infant caudal anesthesia may be responsible
for postoperative apnea. Reg Anesth Pain Med
26:83–85, 2001.
52. Galante D: Preoperative apnea in a preterm infant
after caudal block with ropivacaine and clonidine.
Paediatr Anaesth 15:708–709, 2005.
53. Potts AL, Larsson P, Eksborg S, et al: Clonidine dis-
position in children; a population analysis. Paediatr
Anaesth 17:924–933, 2007.
54. Nafiu OO, Kolawole IK, Salam RA, Elegbe EO:
Comparison of caudal ketamine with or without
bupivacaine in pediatric subumbilical surgery. J Natl
Med Assoc 99:670–673, 2007.
procedimientos de anestesia regional, tanto en los niños como en
los adultos, es un buen testimonio de la eficacia y seguridad de
las técnicas regionales cuando se realizan correctamente. Lo más
probable es que estas técnicas continúen su expansión como téc-
nicas de referencia para el tratamiento del dolor secundario a
procedimientos diagnósticos, quirúrgicos y a traumatismos
siempre que los residentes en anestesiología reciban la formación
adecuada.
Anestesia regional en los niños
2319
71
Sección V
Anestesia pediátrica
© ELSEVIER. Fotocopiar sin autorización es un delito